Zobrazeno 1 - 10
of 332
pro vyhledávání: '"Amir T Fathi"'
Autor:
Shaun Fleming, Gail Roboz, Amir T. Fathi, Tian Y. Zhang, Andrew Wei, Hetty Carraway, Leanne Holes, Erica Petrlik, Thomas Prebet, Daniel Lopes De Menezes, Iryna Bluemmert, Hao Sun, Farhad Ravandi
Publikováno v:
HemaSphere, Vol 7, p e27202d1 (2023)
Externí odkaz:
https://doaj.org/article/aa21f861f6974c24894808e3e451238e
Autor:
Joan How, Siyang Ren, Jennifer Lombardi‐Story, Meghan Bergeron, Julia Foster, Phillip C. Amrein, Andrew M. Brunner, Amir T. Fathi, Hanno Hock, Anna Khachatryan, Hiroto Kikuchi, Mei Rosa Ng, Jenna Moran, Rupa Narayan, Donna Neuberg, Aura Ramos, Tina Som, Meghan Vartanian, Yi‐Bin Chen, Dan G. Duda, Gabriela S. Hobbs
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 434-442 (2022)
Abstract We conducted a single‐center, open‐label, dose escalation, and expansion phase I trial of the antiangiogenic multikinase inhibitor regorafenib in patients with advanced myeloid neoplasms. We enrolled 16 patients with relapsed/refractory
Externí odkaz:
https://doaj.org/article/b768134a01424428b03dc52b7afb2c56
Autor:
Valentina Nardi, Nora Ku, Matthew J. Frigault, Adrian M. Dubuc, Harrison Kwei Tsai, Philip C. Amrein, Gabriela S. Hobbs, Andrew M. Brunner, Rupa Narayan, Meghan E. Burke, Julia Foster, Paola Dal Cin, Marcela V. Maus, Amir T. Fathi, Hanno Hock
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 106-111 (2020)
Abstract: Philadelphia chromosome (Ph)–like acute lymphoblastic leukemia (ALL) is a subtype of Ph-negative ALL that molecularly resembles Ph-positive ALL. It shares the adverse prognosis of Ph-positive ALL, but lacks the BCR-ABL1 fusion oncogene. I
Externí odkaz:
https://doaj.org/article/7fc7238856444e36b2853dd5b133bf4f
Autor:
Daniel A. Pollyea, Jessica K. Altman, Rita Assi, Dale Bixby, Amir T. Fathi, James M. Foran, Ivana Gojo, Aric C. Hall, Brian A. Jonas, Ashwin Kishtagari, Jeffrey Lancet, Lori Maness, James Mangan, Gabriel Mannis, Guido Marcucci, Alice Mims, Kelsey Moriarty, Moaath Mustafa Ali, Jadee Neff, Reza Nejati, Rebecca Olin, Mary-Elizabeth Percival, Alexander Perl, Amanda Przespolewski, Dinesh Rao, Farhad Ravandi, Rory Shallis, Paul J. Shami, Eytan Stein, Richard M. Stone, Kendra Sweet, Swapna Thota, Geoffrey Uy, Pankit Vachhani, Carly J. Cassara, Deborah A. Freedman-Cass, Katie Stehman
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:503-513
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. It is the most common form of acute leukemia among adults and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2bfdc5ec6e73de65bd498c0aa50af4b
https://doi.org/10.6004/jnccn.2023.0025
https://doi.org/10.6004/jnccn.2023.0025
Autor:
Amir T. Fathi, Haesook T. Kim, Robert J. Soiffer, Mark J. Levis, Shuli Li, Annette S. Kim, Zachariah DeFilipp, Areej El-Jawahri, Steve L. McAfee, Andrew M. Brunner, Philip C. Amrein, Alice S. Mims, Laura W. Knight, Devon Kelley, AJ S. Bottoms, Lindsey H. Perry, Jonathan L. Wahl, Jennifer Brock, Elayne Breton, Dylan M. Marchione, Vincent T. Ho, Yi-Bin Chen
Publikováno v:
Clinical Cancer Research. 29:2034-2042
Purpose: Isocitrate dehydrogenase 1 (IDH1) mutations occur in 5% to 10% of patients with acute myeloid leukemia (AML). Ivosidenib is an IDH1 inhibitor, approved for use in patients with IDH1-mutated AML. Patients and Methods: We conducted a multicent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6018d58039b44e1e6368f3333c96f2a6
https://doi.org/10.1158/1078-0432.ccr-23-0182
https://doi.org/10.1158/1078-0432.ccr-23-0182
Autor:
Guillermo Garcia-Manero, Aaron D Goldberg, Eric S Winer, Jessica K Altman, Amir T Fathi, Olatoyosi Odenike, Gail J Roboz, Kendra Sweet, Crystal Miller, Anders Wennborg, Denice K Hickman, Rashmi Kanagal-Shamanna, Hagop Kantarjian, Jeffrey Lancet, Rami Komrokji, Eyal C Attar, David A Sallman
Publikováno v:
The Lancet Haematology. 10:e272-e283
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::498956c3047927105c5def6de0594920
https://doi.org/10.1016/s2352-3026(22)00403-3
https://doi.org/10.1016/s2352-3026(22)00403-3
Autor:
Ashley Ott, Vinayak Venkataraman, Yousef R. Badran, Rose Goldman, Smiljana Spasic, Darshali A. Vyas, Philip Amrein, Steven McAfee, Andrew Brunner, Amir T. Fathi, Rupa Narayan
Publikováno v:
Clinical Case Reports, Vol 9, Iss 5, Pp n/a-n/a (2021)
Abstract Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies ev
Externí odkaz:
https://doaj.org/article/494d082f35284bb09e1061365acbe062
Autor:
Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, Eunice Wang, Jayastu Senapati, Nathaniel R. Wilson, Marina Konopleva, Arthur E. Frankel, Vikas Gupta, Ruben Mesa, Matthew Ulrickson, Edward Gorak, Sumeet Bhatia, Tulin Budak-Alpdogan, James Mason, Maria Teresa Garcia-Romero, Norma Lopez-Santiago, Gabriela Cesarman-Maus, Pankit Vachhani, Sangmin Lee, Vijaya Raj Bhatt, William Blum, Roland B. Walter, Dale Bixby, Ivana Gojo, Madeleine Duvic, Raajit K. Rampal, Marcos de Lima, James Foran, Amir T. Fathi, Aric Cameron Hall, Meagan A. Jacoby, Jeffrey Lancet, Gabriel Mannis, Anthony S. Stein, Alice Mims, David Rizzieri, Rebecca Olin, Alexander Perl, Gary Schiller, Paul Shami, Richard M. Stone, Stephen Strickland, Matthew J. Wieduwilt, Naval Daver, Farhad Ravandi, Sumithira Vasu, Monica Guzman, Gail J. Roboz, Joseph Khoury, Muzaffar Qazilbash, Phyu P. Aung, Branko Cuglievan, Yazan Madanat, Mohamed A. Kharfan-Dabaja, Anna Pawlowska, Justin Taylor, Martin Tallman, Prajwal Dhakal, Andrew A. Lane
Publikováno v:
Blood. 141:567-578
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy with historically poor outcomes and no worldwide consensus treatment approach. Unique among most hematologic malignancies for its frequent cutaneous involvement, BP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f1e80634552189cee8742898d68b12
https://doi.org/10.1182/blood.2022017865
https://doi.org/10.1182/blood.2022017865
Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial
Autor:
Areej El‐Jawahri, Marlise R. Luskin, Joseph A. Greer, Lara Traeger, Mitchell Lavoie, Dagny Marie Vaughn, Stephanie Andrews, Daniel Yang, Kofi Y. Boateng, Richard A. Newcomb, Nneka N. Ufere, Amir T. Fathi, Gabriela Hobbs, Andrew Brunner, Gregory A. Abel, Richard M. Stone, Daniel J. DeAngelo, Martha Wadleigh, Jennifer S. Temel
Publikováno v:
Cancer. 129:1075-1084
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::115348ff64cfb94d4b907d9cd2c57346
https://doi.org/10.1002/cncr.34645
https://doi.org/10.1002/cncr.34645
Autor:
Maximilian Stahl, Michelle DeVeaux, Theo de Witte, Judith Neukirchen, Mikkael A. Sekeres, Andrew M. Brunner, Gail J. Roboz, David P. Steensma, Vijaya R. Bhatt, Uwe Platzbecker, Thomas Cluzeau, Pedro H. Prata, Raphaël Itzykson, Pierre Fenaux, Amir T. Fathi, Alexandra Smith, Ulrich Germing, Ellen K. Ritchie, Vivek Verma, Aziz Nazha, Jaroslaw P. Maciejewski, Nikolai A. Podoltsev, Thomas Prebet, Valeria Santini, Steven D. Gore, Rami S. Komrokji, Amer M. Zeidan
Publikováno v:
Blood Advances, Vol 2, Iss 14, Pp 1765-1772 (2018)
Abstract: Most studies of immunosuppressive therapy (IST) in myelodysplastic syndromes (MDS) are limited by small numbers and their single-center nature, and report conflicting data regarding predictors for response to IST. We examined outcomes assoc
Externí odkaz:
https://doaj.org/article/a5a59ecccd024d588117d21e7d6e571f